Innovative Medicines Initiative
Company Description
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
To know more, please visit www.imi.europa.eu.
Job of the week
EURACTIV News
- Kicking inequality out of Europe using football, Latvia and Ukraine are out in front. [Advocacy Lab Content]
- EU data protection body says Meta’s ‘pay or OK’ model is not OK
- Denmark, Czechia, the Netherlands look to support air defence for Ukraine
- Letta’s report aligns with views of major telecoms on market integration
- Farmers should not bear EU green transition costs alone, says Letta report
Agenda
18 Nov 2024
21 Oct 2024
15 Oct 2024
25 Jun 2024
17 Jun 2024
18 Apr 2024
Subscribe to our jobletter!